Citigroup
ISEE

Citigroup’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Citigroup’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-157,000
Closed -$2.82M – 6072
2022
Q3 		$2.82M Buy
+157,000
New +$2.06M ﹤0.01% 1911
2019
Q1 		– Sell
-5,400
Closed -$6K – 7869
2018
Q4 		$6K Buy
5,400
+900
+20% +$1.74K ﹤0.01% 7321
2018
Q3 		$11K Sell
4,500
-1,500
-25% -$3.74K ﹤0.01% 7333
2018
Q2 		$16K Sell
6,000
-500
-8% -$1.38K ﹤0.01% 7034
2018
Q1 		$18K Buy
6,500
+1,400
+27% +$4.06K ﹤0.01% 6813
2017
Q4 		$16K Sell
5,100
-1,100
-18% -$3.09K ﹤0.01% 6843
2017
Q3 		$17K Sell
6,200
-1,000
-14% -$2.7K ﹤0.01% 6506
2017
Q2 		$18K Buy
7,200
+3,900
+118% +$10.6K ﹤0.01% 6329
2017
Q1 		$12K Sell
3,300
-8,500
-72% -$35.9K ﹤0.01% 6508
2016
Q4 		$57K Buy
11,800
+6,500
+123% +$193K ﹤0.01% 6084
2016
Q3 		$244K Buy
+5,300
New +$299K ﹤0.01% 4511

Citigroup's ISEE Position: Q3 2023 in Review

Citigroup sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 297,957 shares — an estimated $11.7M sold.

Citigroup first reported a position in ISEE in Q4 2013 and held it in 39 quarters. The position peaked at $11.7M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Citigroup reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Citigroup sold 297,957 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $11.7M.
  • Citigroup first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 39 quarters.
  • Citigroup's IVERIC bio, Inc. Common Stock position peaked at $11.7M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.